|Bid||63.23 x 800|
|Ask||63.40 x 900|
|Day's Range||62.62 - 64.68|
|52 Week Range||37.24 - 66.61|
|Beta (3Y Monthly)||1.08|
|PE Ratio (TTM)||15.42|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Zacks Analyst Blog Highlights: Crocs, Kinross Gold, MasTec, Quanex Building Products and Rent-A-Center
We believe that such strong domestic economic data, expectations of a Fed rate cut and trade optimism will continue to act as strong catalysts for the U.S. stock market.
MasTec (MTZ) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks Market Edge Highlights: UnitedHealth, Centene, MasTec, Bank of America and Bristol-Myers Squibb
Quanta Services' (PWR) three accretive acquisitions are likely to unlock significant opportunities, given strong end-market growth dynamics.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Strong backlog and solid prospects in power generation, transmission, communication, and oil & gas businesses are likely to help MasTec (MTZ) to grow further.